Evidence map›Paper›PMID 30666499›Full record

ArticleMedical oncology (Northwood, London, England)2019

A feedback regulation of CREB activation through the CUL4A and ERK signaling.

Cheemala Ashok, Sheikh Owais, Loudu Srijyothi, Murugan Selvam, Saravanaraman Ponne, Sudhakar Baluchamy

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Exogenous NADBiomolecules · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cheemala AshokDepartment of Biotechnology, Pondicherry Central University, Pondicherry, 605014, India.
Sheikh OwaisDepartment of Biotechnology, Pondicherry Central University, Pondicherry, 605014, India.
Loudu SrijyothiDepartment of Biotechnology, Pondicherry Central University, Pondicherry, 605014, India.
Murugan SelvamDepartment of Biotechnology, Pondicherry Central University, Pondicherry, 605014, India.
Saravanaraman PonneDepartment of Biotechnology, Pondicherry Central University, Pondicherry, 605014, India.
Sudhakar BaluchamyDepartment of Biotechnology, Pondicherry Central University, Pondicherry, 605014, India. baluchamy@yahoo.com.ORCID http://orcid.org/0000-0003-2398-8480
Pondicherry University · IN

Funding

Science and Engineering Research Board NPDF 2739Science and Engineering Research Board SB/EMEQ-038/2013
6 · The paper itself

Abstract

CUL4A; an E3 ubiquitin ligase is involved in the degradation of negative regulators of cell cycle such as p21, p27, p53, etc., through polyubiquitination-mediated protein degradation. The functional role(s) of CUL4A proteins on their targets are well characterized; however, the transcriptional regulation of CUL4A, particularly at its promoter level is not yet studied. Therefore, in this study, using computational tools, we found cAMP responsive elements (CRE) at the locations of - 926 and - 764 with respect to transcription state site + 1 of CUL4A promoter. Hence, we investigated the role of CREB on the regulation of CUL4A transcription. Our chromatin immunoprecipitation (ChIP) data clearly showed increased levels of promoter occupancy of both CREB and pCREB on both CREs of CUL4A promoter. As expected, the expression of CUL4A increases and decreases upon the overexpression of and knocking down of CREB, respectively. Moreover, the inhibition of ERK pathway by U0126 not only reduces the CREB activation but also the CUL4A levels suggesting that CREB is the upstream activator of CUL4A transcription. The reduction of CUL4A levels upon the knocking down of CREB or by U0126 treatment increases the protein levels of CUL4A substrates such as p21 and p27. It is reported that CUL4A activates the ERK1/2 transcription and ERK1/2 pathway activates the CREB by phosphorylation. Based on our data and earlier findings, we report that CREB regulates the CUL4A levels positively which in turn activates the CREB through ERK1/2 pathway in the form of auto-regulatory looped mechanism.This suggests that CUL4A might be involved in proliferation of cancer cells by regulating the ERK1/2 and CREB signaling.

Indexed as

Feedback, PhysiologicalCullin ProteinsCyclic AMP Response Element-Binding ProteinExtracellular Signal-Regulated MAP KinasesGene Expression RegulationHeLa CellsHumansMAP Kinase Signaling SystemPromoter Regions, GeneticCREB1 protein, humanCUL4A protein, humanCullin ProteinsCyclic AMP Response Element-Binding ProteinExtracellular Signal-Regulated MAP KinasescAMP response element (CRE)CREBCUL4AERK1/2Transcriptional regulationU0126

Identifiers

PMID30666499
OpenAlexW2911459086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.